Diagnosing MDR infections in cancer patients can be challenging due to overlapping symptoms between infections and cancer or its treatments. Advanced diagnostic techniques like polymerase chain reaction (PCR), mass spectrometry, and next-generation sequencing are often required to identify the specific pathogen and its resistance profile accurately.
